Signos

Signos is a metabolic health platform that pairs continuous glucose monitoring (CGM) with an AI-driven app to provide real-time, personalized insights for weight management and healthy weight loss. The platform targets non-diabetic adults seeking to improve metabolic health, offering personalized meal, exercise, and lifestyle recommendations based on each user's unique glucose response. In 2025, Signos received FDA clearance for the first over-the-counter glucose monitoring system designed specifically for weight management.